13.1(top 1%)
impact factor
430(top 50%)
papers
14.8K(top 20%)
citations
66(top 10%)
h-index
13.4(top 1%)
impact factor
751
all documents
19.1K
doc citations
100(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Discovering the anticancer potential of non-oncology drugs by systematic viability profilingNature Cancer2020430
2The impact of the COVID-19 pandemic on cancer careNature Cancer2020392
3Pan-cancer image-based detection of clinically actionable genetic alterationsNature Cancer2020343
4Pan-cancer computational histopathology reveals mutations, tumor composition and prognosisNature Cancer2020339
5Circulating tumor DNA and liquid biopsy in oncologyNature Cancer2020309
6Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumabNature Cancer2020253
7PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancerNature Cancer2020240
8Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancerNature Cancer2020234
9Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerNature Cancer2020218
10Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancerNature Cancer2020209
11Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myelomaNature Cancer2020209
12Cancer vaccines: the next immunotherapy frontierNature Cancer2022207
13Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancerNature Cancer2020201
14Overcoming therapy resistance in EGFR-mutant lung cancerNature Cancer2021198
15Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunityNature Cancer2020178
16Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expressionNature Cancer2021173
17A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumorsNature Cancer2021168
18A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependenciesNature Cancer2020166
19Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilitiesNature Cancer2021163
20Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcomeNature Cancer2020159
21Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancerNature Cancer2022150
22Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneityNature Cancer2021147
23Fatty acid synthesis is required for breast cancer brain metastasisNature Cancer2021147
24Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunityNature Cancer2021147
25Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancerNature Cancer2020141
26Cancer-associated fibroblasts in the single-cell eraNature Cancer2022141
27Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulationNature Cancer2020140
28The metabolic landscape of RAS-driven cancers from biology to therapyNature Cancer2021139
29Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapyNature Cancer2020138
30Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cellsNature Cancer2020137
31L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancerNature Cancer2020137
32A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncologyNature Cancer2022133
33The current paradigm and challenges ahead for the dormancy of disseminated tumor cellsNature Cancer2020132
34Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancerNature Cancer2021126
35Molecular pathogenesis and systemic therapies for hepatocellular carcinomaNature Cancer2022126
36A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinomaNature Cancer2020124
37Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE studyNature Cancer2021123
38Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncologyNature Cancer2022119
39EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancerNature Cancer2021118
40Artificial intelligence in histopathology: enhancing cancer research and clinical oncologyNature Cancer2022115
41Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapyNature Cancer2020114
42Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunityNature Cancer2020113
43Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialNature Cancer2021112
44Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomasNature Cancer2021110
45A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancyNature Cancer2022110
46Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemiaNature Cancer2020108
47A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneityNature Cancer2020103
48Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapesNature Cancer2020103
49Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanomaNature Cancer2021102
50Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaNature Cancer202199